Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page adds new help/navigation items and shows recruitment status as No longer looking for participants. The intervention header changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded a new revision entry v3.5.5 to the page's revision history along with the associated dates (2026-06-02, 2027-04, 2026-05-29). Removed the previous revision entry v3.5.4 and its dates (2026-05-26, 2032-05, 2026-05-21).SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a revision of enrollment/time-related fields: old status values such as Recruiting and Completed were removed, while new date fields with Actual/Estimated labels (including 2026-05-26, 2026-05-21, 2026-05, 2032-05) were added to reflect updated timelines.SummaryDifference4%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.5.4 and removed ancillary items including Related Info, AbbVie, Helpful Links Provided by, and Revision: v3.5.3. These changes reflect a maintenance/update of the page rather than substantive updates to the study content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the study record itself.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.